Please use this identifier to cite or link to this item:
|Title:||Acupuncture: A Promising Approach for Comorbid Depression and Insomnia in Perimenopause.||Austin Authors:||Zhao, Fei-Yi;Fu, Qiang-Qiang;Spencer, Sarah J;Kennedy, Gerard A ;Conduit, Russell;Zhang, Wen-Jing;Zheng, Zhen||Affiliation:||Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People's Republic of China
Institute for Breathing and Sleep
School of Science, Psychology and Sport, Federation University, Mount Helen, Victoria, Australia
ARC Centre of Excellence for Nanoscale Biophotonics, RMIT University, Bundoora, Victoria, 3083, Australia
Department of Nursing, School of International Medical Technology, Shanghai Sanda University, Shanghai, 201209, People's Republic of China..
School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, 3083, Australia
Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, People's Republic of China
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People's Republic of China..
|Issue Date:||12-Oct-2021||metadata.dc.date:||2021||Publication information:||Nature and Science of Sleep 2021; 13: 1823-1863||Abstract:||Comorbid depression and insomnia are ubiquitous mental complaints among women going through the perimenopausal stage of life and can result in major decline in quality of life. Antidepressive agents combined with/without hypnotics, and/or hormone therapy are currently the most common treatment for perimenopausal depression (PMD) and insomnia (PMI). Balancing the benefits of these pharmacotherapies against the risk of adverse events (AEs) is a difficult task for both clinicians and women. There has been a growing body of research regarding the utilization of acupuncture for treatment of PMD or PMI, whereas no studies of acupuncture for comorbid PMD and PMI have appeared. In this review, we summarize the clinical and preclinical evidence of acupuncture as a treatment for PMD or PMI, and then discuss the potential mechanisms involved and the role of acupuncture in helping women during this transition. Most clinical trials indicate that acupuncture ameliorates not only PMD/PMI but also climacteric symptoms with minimal AEs. It also regulates serum hormone levels. The reliability of trials is however limited due to methodological flaws in most studies. Rodent studies suggest that acupuncture prolongs total sleep time and reduces depression-like behavior in PMI and PMD models, respectively. These effects are possibly mediated through multiple mechanisms of action, including modulating sex hormones, neurotransmitters, hypothalamic-pituitary-adrenal axis/hypothalamic-pituitary-ovary axis, oxidative stress, signaling pathways, and other cellular events. In conclusion, acupuncture is a promising therapeutic strategy for comorbid depression and insomnia during perimenopause. Neuroendocrine modulation is likely to play a major role in mediating those effects. High-quality trials are required to further validate acupuncture's effectiveness.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/27778||DOI:||10.2147/NSS.S332474||ORCID:||0000-0001-9009-8870
|Journal:||Nature and Science of Sleep||PubMed URL:||34675729||ISSN:||1179-1608||Type:||Journal Article||Subjects:||acupuncture
|Appears in Collections:||Journal articles|
Show full item record
checked on Jun 8, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.